Corporate News 30-May-24
Board of Gufic BioSciences recommends final dividend
Of Rs 0.1 per share
Gufic BioSciences announced that the Board of Directors of the Company at its meeting held on 29 May 2024, inter alia, have recommended the final dividend of Rs 0.1 per equity Share (i.e. 10%) , subject to the approval of the shareholders.
Previous News
Gufic BioSciences standalone net profit declines 10.61% in the March 2023 quarter
( Results - Announcements 30-May-23 07:46 )
Gufic BioSciences standalone net profit rises 279.77% in the September 2020 quarter
( Results - Announcements 13-Nov-20 08:31 )
Board of Gufic BioSciences approves change in directorate
( Corporate News - 27-Jun-24 18:11 )
Gufic Bioscience receives CDSCO nod to manufacture and sale of Antifungal drug
( Hot Pursuit - 11-Apr-22 17:45 )
Gufic BioSciences to conduct AGM
( Corporate News - 05-Sep-23 15:21 )
Gufic BioSciences grants 6,000 stock options
( Corporate News - 27-Jun-24 18:04 )
Board of Gufic BioSciences recommends final dividend
( Corporate News - 01-Jun-15 14:33 )
Gufic BioSciences standalone net profit declines 44.00% in the March 2015 quarter
( Results - Announcements 01-Jun-15 14:22 )
Board of Gufic BioSciences accepts cessation of director
( Corporate News - 15-Sep-20 09:05 )
Gufic BioSciences net profit rises 12.90% in the June 2007 quarter
( Results - Announcements 01-Aug-07 19:25 )
Gufic BioSciences to hold board meeting
( Corporate News - 10-Sep-20 15:04 )
Other Stories
RailTel wins order of Rs 23.96 cr
04-Jul-24 19:25
Unicycive enters into manufacturing and supply agreement with Shipla Medicare
04-Jul-24 18:55
Mahindra Lifespace Developers acquires 2.37 land for development in South Bengaluru
04-Jul-24 18:27
Mahindra Lifespace Developers to undertake redevelopment project in Borivali, Mumbai
04-Jul-24 18:25
Ahluwalia Contracts wins order of Rs 572 cr
04-Jul-24 18:13
Dilip Buildcon divest 51% stake in project SPV (Pathrapali Kathgora Highways)
04-Jul-24 18:06
NBCC (India) wins work order from National Institute of Technology
04-Jul-24 16:15
CAMS appoints director
04-Jul-24 16:13
Alembic Pharmaceuticals receives USFDA tentative approval for Ivosidenib Tablets
04-Jul-24 16:11
Board of Lloyds Metals & Energy approves allotment of convertible warrants aggregating Rs 2960 cr
04-Jul-24 16:07
Back
Top
